The 20 Best Myelodysplastic Syndrome (MDS) Doctors Near Me in Michigan, US

Andrew Muskovitz is a Hematologist and an Oncologist practicing medicine in Sterling Heights, Michigan. He has been practicing medicine for over 21 years. Dr. Muskovitz is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 102 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Thrombocytopenia, Bone Marrow Aspiration, and Ureteroscopy. Dr. Muskovitz is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Muskovitz is currently accepting new patients.

Brett Brinker is a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 26 years. Dr. Brinker is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 60 other conditions, according to our data. His clinical expertise encompasses B-Cell Lymphoma, Acute Myeloid Leukemia (AML), Non-Hodgkin Lymphoma, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Brinker is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Brinker is currently accepting new patients.

Mohammed Ogaily is an Oncologist practicing medicine in Brownstown Twp, Michigan. He has been practicing medicine for over 39 years. Dr. Ogaily is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 50 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Lynch Syndrome, Colorectal Cancer, and Paget Disease of the Breast. Dr. Ogaily is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Ogaily is currently accepting new patients.

Adil Akhtar is a Palliative Medicine specialist and an Oncologist practicing medicine in Sterling Heights, Michigan. He has been practicing medicine for over 41 years. Dr. Akhtar is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, Lung Adenocarcinoma, Bone Marrow Aspiration, and Gastrostomy. Dr. Akhtar is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Akhtar is currently accepting new patients.

Erin Pettijohn is a Hematologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 15 years. Dr. Pettijohn is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). She is also highly rated in 47 other conditions, according to our data. Her clinical expertise encompasses Large-Cell Immunoblastic Lymphoma, B-Cell Lymphoma, Chronic Lymphocytic Leukemia (CLL), Diffuse Large B-Cell Lymphoma (DLBCL), and Bone Marrow Aspiration. Dr. Pettijohn is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Pettijohn is currently accepting new patients.

Latha Polavaram is a Hematologist and a Hematologist Oncology provider practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 27 years. Dr. Polavaram is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). She is also highly rated in 73 other conditions, according to our data. Her clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, B-Cell Lymphoma, Anaplastic Large Cell Lymphoma, and Bone Marrow Aspiration. Dr. Polavaram is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Polavaram is currently accepting new patients.

Deepa Jagtap is a Hematologist and an Oncologist practicing medicine in Royal Oak, Michigan. Dr. Jagtap is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). She is also highly rated in 35 other conditions, according to our data. Her clinical expertise encompasses Adult Immune Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, and Bone Marrow Aspiration. Dr. Jagtap is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Jagtap is currently accepting new patients.

Kelly Parling is an Otolaryngologist and a Hematologist Oncology provider practicing medicine in Holland, Michigan. She has been practicing medicine for over 27 years. Dr. Parling is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Lung Cancer, Myelodysplastic Syndrome (MDS), and Neuroendocrine Tumor. Dr. Parling is board certified in American Osteopathic Board Of Internal Medicine. Dr. Parling is currently accepting new patients.

Andrew Sochacki is a Hematologist Oncology specialist and an Oncologist practicing medicine in Grand Rapids, Michigan. He has been practicing medicine for over 12 years. Dr. Sochacki is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, and Bone Marrow Aspiration. Dr. Sochacki is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Sochacki is currently accepting new patients.

Stephanie Dublis is a Hematologist and an Oncologist practicing medicine in Grand Rapids, Michigan. She has been practicing medicine for over 22 years. Dr. Dublis is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, Angiosarcoma, and Bone Marrow Aspiration. Dr. Dublis is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Dublis is currently accepting new patients.

Kathryn Alguire is a Hematologist Oncology specialist and an Oncologist practicing medicine in Norton Shores, Michigan. She has been practicing medicine for over 27 years. Dr. Alguire is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Alguire is board certified in American Board Of Internal Medicine. Dr. Alguire is currently accepting new patients.

Samir Alsawah is an Oncologist practicing medicine in Sterling Heights, Michigan. He has been practicing medicine for over 43 years. Dr. Alsawah is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Myelodysplastic Syndrome (MDS), ALK-Positive Non-Small Cell Lung Cancer, Non-Hodgkin Lymphoma, Agranulocytosis, and Bone Marrow Aspiration. Dr. Alsawah is board certified in American Board Of Internal Medicine. Dr. Alsawah is currently accepting new patients.

Yusuf Qamruzzaman is a Hematologist and an Oncologist practicing medicine in Royal Oak, Michigan. He has been practicing medicine for over 19 years. Dr. Qamruzzaman is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Agranulocytosis, Chronic Familial Neutropenia, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Qamruzzaman is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Qamruzzaman is currently accepting new patients.

Eric Batts is a Hematologist Oncology specialist and an Oncologist practicing medicine in Holland, Michigan. He has been practicing medicine for over 25 years. Dr. Batts is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Pleuropulmonary Blastoma, and Myelodysplastic Syndrome (MDS). Dr. Batts is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine, and American Board Of Internal Medicine. Dr. Batts is currently accepting new patients.

George Howard is an Oncologist practicing medicine in Sterling Heights, Michigan. He has been practicing medicine for over 24 years. Dr. Howard is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 113 other conditions, according to our data. His clinical expertise encompasses Adult Immune Thrombocytopenia, Familial Colorectal Cancer, Hemangioma Thrombocytopenia Syndrome, Bone Marrow Aspiration, and Gastrostomy. Dr. Howard is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Howard is currently accepting new patients.

Bhadresh Nayak is an Oncologist practicing medicine in Sterling Heights, Michigan. He has been practicing medicine for over 40 years. Dr. Nayak is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 90 other conditions, according to our data. His clinical expertise encompasses Hereditary Resistance to Anti-Vitamin K, Protein S Deficiency, Congenital Antithrombin 3 Deficiency, Bone Marrow Aspiration, and Gastrostomy. Dr. Nayak is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Nayak is currently accepting new patients.

Anup Lal is a Hematologist and an Oncologist practicing medicine in Port Huron, Michigan. He has been practicing medicine for over 31 years. Dr. Lal is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 58 other conditions, according to our data. His clinical expertise encompasses Transient Erythroblastopenia of Childhood, Pure Red Cell Aplasia, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Lal is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Lal is currently accepting new patients.

Dr. Dale Bixby has been practicing hematology at the University of Michigan since 2009. He obtained his PhD in Medicinal Chemistry and Pharmaceutics at the University of Kentucky in 1999, before beginning his medical training at the University of Michigan in Ann Arbor, MI. He was a resident in the Department of Internal Medicine and then completed fellowship training in hematology and medical oncology at the University of Michigan. Dr. Bixby is currently a clinical professor and specializes in the areas of myeloid and lymphoid leukemias, myelodysplastic syndrome and bone marrow failure disorders. Dr. Bixby currently serves as the section chief of the acute leukemia program. He is also a clinical investigator in hematological malignancies. Dr. Bixby is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Chronic Myelogenous Leukemia (CML), and Bone Marrow Aspiration. Dr. Bixby is board certified in Hematology.

Dr. Burke joined the faculty in July 2014. He attended Providence College in Rhode Island where he earned his BS in Biology. Subsequently, he matriculated at the Icahn School of Medicine at Mount Sinai and earned his MD. He then completed a residency in Internal Medicine at the University of Chicago Medical Center, followed by a year serving as a Chief Resident. He recently completed his Hematology/Medical Oncology fellowship at Memorial Sloan Kettering Cancer Center in New York where his clinical and research interests focused on leukemia, particularly adult acute lymphoblastic leukemia (ALL). He performed clinical research regarding the role of asparaginase and “pediatric-inspired” therapeutic regimens in adult ALL, as well as investigating therapies that spare cytotoxic chemotherapy in older adult Philadelphia chromosome-positive ALL. Dr. Burke is focused on early phase clinical trials in acute leukemias and is treating patients with hematologic malignancies. Dr. Burke is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Aplastic Anemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Burke is board certified in Hematology and Medical Oncology.

Dr. Pettit studied physics and magazine journalism at Syracuse University prior to earning her MD from the Chicago Medical School. She went on to complete her residency in internal medicine and fellowships in hematology/oncology and clinical pharmacology/pharmacogenomics at the University of Chicago. She has received national recognition for her research, including the Conquer Cancer Foundation/ASCO Young Investigator Award, the ASCPT Presidential Trainee Award, and selection for the ASH Clinical Research Training Institute. Dr. Pettit focuses on translational research and drug development for patients with myeloid malignancies, specifically myeloproliferative neoplasms, myelodysplastic syndrome, and acute myeloid leukemia. Dr. Pettit is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Myelofibrosis, Myeloproliferative Neoplasms (MPN), Acute Myeloid Leukemia (AML), Bone Marrow Aspiration, and Splenectomy. Dr. Pettit is board certified in Medical Oncology and Hematology.